Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2022 Filed Mar 1, 2022 21:23 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Tax withholdingHumana Common | 1,446 | $428.27 | $619,278.42 |
DisclosureSEC source: 0001062993-22-006116 · form4.xml · nonDerivative · entry 2 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:23 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionHumana Common | 3,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006116 · form4.xml · nonDerivative · entry 1 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Performance Stock Units vesting on 2/25/22, not required to be reported until vest. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:23 UTC |
Ventura Joseph CChief Legal Officer
|
Tax withholdingHumana Common | 888 | $428.27 | $380,303.76 |
DisclosureSEC source: 0001062993-22-006119 · form4.xml · nonDerivative · entry 2 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,156 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:23 UTC |
Ventura Joseph CChief Legal Officer
|
Exercise / conversionHumana Common | 2,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006119 · form4.xml · nonDerivative · entry 1 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:22 UTC |
Deshpande SamirChief Information Officer
|
Tax withholdingHumana Common | 1,445 | $428.27 | $618,850.15 |
DisclosureSEC source: 0001062993-22-006111 · form4.xml · nonDerivative · entry 2 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,486 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:22 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionHumana Common | 3,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006111 · form4.xml · nonDerivative · entry 1 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:22 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Tax withholdingHumana Common | 11,360 | $428.27 | $4,865,147.20 |
DisclosureSEC source: 0001062993-22-006113 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,649 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:22 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 29,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006113 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:21 UTC |
Cox HeatherChief Dig Health & Analyt Off.
|
Tax withholdingHumana Common | 1,217 | $428.27 | $521,204.59 |
DisclosureSEC source: 0001062993-22-006109 · form4.xml · nonDerivative · entry 2 Cox Heather · CIK 0001734706 · Chief Dig Health & Analyt Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,014 F12 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:21 UTC |
Cox HeatherChief Dig Health & Analyt Off.
|
Exercise / conversionHumana Common | 3,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006109 · form4.xml · nonDerivative · entry 1 Cox Heather · CIK 0001734706 · Chief Dig Health & Analyt Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:16 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Tax withholdingHumana Common | 2,079 | $428.27 | $890,373.33 |
DisclosureSEC source: 0001062993-22-006100 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,757 F13 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:16 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionHumana Common | 5,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006100 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC |
Huval Timothy S.Chief Administrative Officer
|
Tax withholdingHumana Common | 1,707 | $428.27 | $731,056.89 |
DisclosureSEC source: 0001062993-22-006096 · form4.xml · nonDerivative · entry 2 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,684 F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC |
Huval Timothy S.Chief Administrative Officer
|
Exercise / conversionHumana Common | 4,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006096 · form4.xml · nonDerivative · entry 1 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:14 UTC |
Wheatley Timothy AlanSegment President, Retail
|
Tax withholdingHumana Common | 2,363 | $428.27 | $1,012,002.01 |
DisclosureSEC source: 0001062993-22-006093 · form4.xml · nonDerivative · entry 2 Wheatley Timothy Alan · CIK 0001699799 · Segment President, Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,122 F14 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:14 UTC |
Wheatley Timothy AlanSegment President, Retail
|
Exercise / conversionHumana Common | 5,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006093 · form4.xml · nonDerivative · entry 1 Wheatley Timothy Alan · CIK 0001699799 · Segment President, Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:13 UTC |
Zipperle Cynthia HSVP, Chief Acct Officer & Cont
|
Tax withholdingHumana Common | 427 | $428.27 | $182,871.29 |
DisclosureSEC source: 0001062993-22-006090 · form4.xml · nonDerivative · entry 2 Zipperle Cynthia H · CIK 0001628102 · SVP, Chief Acct Officer & Cont 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,723 F7 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/25/22. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:13 UTC |
Zipperle Cynthia HSVP, Chief Acct Officer & Cont
|
Exercise / conversionHumana Common | 1,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006090 · form4.xml · nonDerivative · entry 1 Zipperle Cynthia H · CIK 0001628102 · SVP, Chief Acct Officer & Cont 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Performance Stock Units vested on 2/25/22, not required to be reported until vest. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 23:09 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
GrantRestricted Stock Units · Derivative | 1,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005413 · form4.xml · derivative · entry 10 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035 Underlying: Humana Common · 1,035 shares Expires not disclosed F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 23:09 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
GrantOptions · Derivative | 3,750 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005413 · form4.xml · derivative · entry 7 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Humana Common · 3,750 shares Expires 2029-02-21 F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 23:09 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 6,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005412 · form4.xml · derivative · entry 9 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,551 Underlying: Humana Common · 6,551 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 23:09 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
GrantOptions · Derivative | 23,734 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005412 · form4.xml · derivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,734 Underlying: Humana Common · 23,734 shares Expires 2029-02-21 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:58 UTC |
Ventura Joseph CChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 1,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005411 · form4.xml · derivative · entry 9 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Humana Common · 1,085 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:58 UTC |
Ventura Joseph CChief Legal Officer
|
GrantOptions · Derivative | 3,932 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005411 · form4.xml · derivative · entry 6 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,932 Underlying: Humana Common · 3,932 shares Expires 2029-02-21 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:56 UTC |
Huval Timothy S.Chief Administrative Officer
|
GrantRestricted Stock Units · Derivative | 1,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005410 · form4.xml · derivative · entry 8 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Humana Common · 1,085 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:56 UTC |
Huval Timothy S.Chief Administrative Officer
|
GrantOptions · Derivative | 3,932 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005410 · form4.xml · derivative · entry 5 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,932 Underlying: Humana Common · 3,932 shares Expires 2029-02-21 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:55 UTC |
Wheatley Timothy AlanSegment President, Retail
|
GrantRestricted Stock Units · Derivative | 1,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005408 · form4.xml · derivative · entry 11 Wheatley Timothy Alan · CIK 0001699799 · Segment President, Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,482 Underlying: Humana Common · 1,482 shares Expires not disclosed F8 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F11 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F11 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:55 UTC |
Wheatley Timothy AlanSegment President, Retail
|
GrantOptions · Derivative | 5,370 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005408 · form4.xml · derivative · entry 8 Wheatley Timothy Alan · CIK 0001699799 · Segment President, Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,370 Underlying: Humana Common · 5,370 shares Expires 2029-02-21 F7 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F7 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:51 UTC |
Deshpande SamirChief Information Officer
|
GrantRestricted Stock Units · Derivative | 1,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005400 · form4.xml · derivative · entry 9 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,059 Underlying: Humana Common · 1,059 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:51 UTC |
Deshpande SamirChief Information Officer
|
GrantOptions · Derivative | 3,836 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005400 · form4.xml · derivative · entry 6 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,836 Underlying: Humana Common · 3,836 shares Expires 2029-02-21 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:43 UTC |
Diamond Susan MChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 1,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005397 · form4.xml · derivative · entry 12 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535 Underlying: Humana Common · 1,535 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F12 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F12 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:43 UTC |
Diamond Susan MChief Financial Officer
|
GrantOptions · Derivative | 5,562 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005397 · form4.xml · derivative · entry 6 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,562 Underlying: Humana Common · 5,562 shares Expires 2029-02-21 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:50 UTC |
Cox HeatherChief Dig Health & Analyt Off.
|
GrantRestricted Stock Units · Derivative | 794 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005399 · form4.xml · derivative · entry 10 Cox Heather · CIK 0001734706 · Chief Dig Health & Analyt Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 794 Underlying: Humana Common · 794 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:50 UTC |
Cox HeatherChief Dig Health & Analyt Off.
|
GrantOptions · Derivative | 2,877 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005399 · form4.xml · derivative · entry 7 Cox Heather · CIK 0001734706 · Chief Dig Health & Analyt Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,877 Underlying: Humana Common · 2,877 shares Expires 2029-02-21 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:42 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
GrantRestricted Stock Units · Derivative | 926 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005396 · form4.xml · derivative · entry 9 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 926 Underlying: Humana Common · 926 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:42 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
GrantOptions · Derivative | 3,356 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005396 · form4.xml · derivative · entry 6 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Underlying: Humana Common · 3,356 shares Expires 2029-02-21 F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:35 UTC |
Shrank William HChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 873 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005393 · form4.xml · derivative · entry 9 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 873 Underlying: Humana Common · 873 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:35 UTC |
Shrank William HChief Medical Officer
|
GrantOptions · Derivative | 3,165 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005393 · form4.xml · derivative · entry 5 Shrank William H · CIK 0001772348 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,165 Underlying: Humana Common · 3,165 shares Expires 2029-02-21 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:35 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
GrantRestricted Stock Units · Derivative | 741 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005392 · form4.xml · derivative · entry 8 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741 Underlying: Humana Common · 741 shares Expires not disclosed F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 22:35 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
GrantOptions · Derivative | 2,685 | $0.00 Strike: $425.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005392 · form4.xml · derivative · entry 3 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,685 Underlying: Humana Common · 2,685 shares Expires 2029-02-21 F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 14:50 UTC |
Klevorn Marcy SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005042 · form4.xml · derivative · entry 2 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 2/17/2022 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 2/17/2022 and forfeited in its entirety if service is less than one year. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 14:50 UTC |
Klevorn Marcy SDirector
|
Exercise / conversionHumana Common | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005042 · form4.xml · nonDerivative · entry 1 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 14:50 UTC |
Mesquita Jorge S.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005044 · form4.xml · derivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 2/17/2022 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 2/17/2022 and forfeited in its entirety if service is less than one year. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 14:50 UTC |
Mesquita Jorge S.Director
|
Exercise / conversionHumana Common | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005044 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 412 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/22. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:02 UTC |
Bono Raquel C.Director
|
GrantRestricted Stock Units · Derivative | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000219 · form4.xml · derivative · entry 4 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412 Underlying: Humana Common · 412 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 14:38 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000113 · form4.xml · derivative · entry 5 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412 Underlying: Humana Common · 412 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2022. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2022. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2022. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2022. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 14:00 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000097 · form4.xml · derivative · entry 5 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412 Underlying: Humana Common · 412 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 14:34 UTC |
Frederick Wayne A.I.Director
|
GrantRestricted Stock Units · Derivative | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000111 · form4.xml · derivative · entry 4 Frederick Wayne A.I. · CIK 0001802241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412 Underlying: Humana Common · 412 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 14:20 UTC |
McDonald William J.Director
|
GrantRestricted Stock Units · Derivative | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000100 · form4.xml · derivative · entry 5 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412 Underlying: Humana Common · 412 shares Expires not disclosed F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 20:28 UTC |
PETERSON MARISSA TDirector
|
GrantHumana Common | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000583 · form4.xml · nonDerivative · entry 1 PETERSON MARISSA T · CIK 0001220067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,044 F3 · balance_after: Includes 412 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/22. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.